Our recent discovery that decorin deficiency promotes EMT and colon cancer metastasis [119] is supported by the observations that exogenous decorin inhibits EMT in glioma cells [118] as well as inflammatory breast cancer growth and metastasis [120]. The gene discussed is DCN; the disease is glioma.